Natalie Dales
Chief of Research Operations and Portfolio Strategy · 1 filing · Latest: May 7, 2026
Odyssey Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|
Chief of Research Operations and Portfolio Strategy · 1 filing · Latest: May 7, 2026
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|